ORIBASE PHARMA has a total of 35 patent applications. Its first patent ever was published in 2010. It filed its patents most often in Australia, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are KYPHA INC, GRAINGER DAVID JOHN and XENON GENETICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | Canada | 4 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | France | 3 | |
#5 | Republic of Korea | 3 | |
#6 | United States | 3 | |
#7 | WIPO (World Intellectual Property Organization) | 3 | |
#8 | Brazil | 2 | |
#9 | China | 2 | |
#10 | Hong Kong | 2 | |
#11 | Argentina | 1 | |
#12 | Chile | 1 | |
#13 | Hungary | 1 | |
#14 | Israel | 1 | |
#15 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement | |
#4 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Analysing materials | |
#4 | Medical preparations | |
#5 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Yasri Abdelaziz | 29 |
#2 | Bories Cedric | 18 |
#3 | Cheve Gwenael | 17 |
#4 | Fauvel Benedicte | 15 |
#5 | Dayde-Cazals Benedicte | 12 |
#6 | Cheve Gwénaël | 11 |
#7 | Bories Cédric | 11 |
#8 | Dayde-Cazals Bénédicte | 10 |
#9 | Fauvel Bénédicte | 9 |
#10 | Delon Louis | 4 |
Publication | Filing date | Title |
---|---|---|
FR3000494A1 | Novel azaindole derivatives as inhibitors of protein kinases | |
FR3000492A1 | Novel azaindole derivatives as multikinase inhibitors | |
FR3000493A1 | New inhibitors of protein kinases | |
AU2010212560A1 | Derivatives of azaindoles as inhibitors of protein kinases Abl and Src |